The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors.
about
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.Comparative investigation of the effects of specific antigen‑sensitized DC‑CIK and DC‑CTL cells against B16 melanoma tumor cells.CIK Cells and HDAC Inhibitors in Multiple Myeloma.Increased Efficacy of Brentuximab Vedotin (SGN-35) in Combination with Cytokine-Induced Killer Cells in Lymphoma.Mesothelin-targeting chimeric antigen receptor-modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma.Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells.Influence of different ex vivo cell culture methods on the proliferation and anti-tumor activity of cytokine-induced killer cells from gastric cancer patients.
P2860
Q33429758-6A8D0458-E512-4626-80A9-FC125D320D56Q37138378-13692446-5FA8-4373-93DF-09AE89444979Q37720231-06D68CD2-35CC-49AC-A7F6-AED7C54D10C4Q38705046-76B582D8-D225-4A87-8082-DB0B19772719Q38759986-93B6101E-B55F-4621-8FBF-9A41945627CFQ40256333-20F00630-7DF9-4CD5-BA81-DEE3BD2ED8ADQ47552123-3835DD6E-7E72-456D-81F2-2D0B77D36D5BQ55034487-0E34B2D6-CB56-4B12-9325-1CD410AE5FFA
P2860
The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The combination of dendritic c ...... atients with malignant tumors.
@ast
The combination of dendritic c ...... atients with malignant tumors.
@en
type
label
The combination of dendritic c ...... atients with malignant tumors.
@ast
The combination of dendritic c ...... atients with malignant tumors.
@en
prefLabel
The combination of dendritic c ...... atients with malignant tumors.
@ast
The combination of dendritic c ...... atients with malignant tumors.
@en
P2093
P2860
P1476
The combination of dendritic c ...... atients with malignant tumors.
@en
P2093
Fuping Zhou
Huajun Jin
Jingbo Chen
Linfang Li
Qijun Qian
Zenghui Xu
P2860
P2888
P356
10.1186/S40164-015-0027-9
P577
2015-11-10T00:00:00Z
P5875
P6179
1028604831